Form 4/A for OPRX OptimizeRx Corp
Accepted 2024-12-27 00:00:00 ET · period of report 2024-02-15 · accession 0001628280-24-052517 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2024-12-27 | 2024-02-15 | OPRX | Stelmakh Edward | CFO, COO | A - Grant | — | 0 | 33.4K | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-15 | A | A | 0 | $0.00 | 33,365 | D | — | — | (F1) On April 24, 2024, the reporting person filed a Form 4 (the "Original Form 4") which inadvertently understated in column 5 the number of shares directly owned by the reporting person following the reported transaction. This inadvertent understatement has been corrected in this amended filing. This understatement also affected the holdings reported in subsequently filed Forms 4, but will be corrected in any Forms 4 filed after the date of this amended filing. |